Skip to content

Moderna MRNA Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin210.2%+32.5pp177.7%-14.4pp192.1%-126pp318.1%-32.6pp
Operating margin-537%-170pp-366.8%-312pp-54.3%-305pp250.8%+36.9pp
Net margin-484.8%-86.2pp-398.6%-332pp-66.9%-291pp224.3%+26.9pp
EBITDA margin-503.8%-171pp-332.7%-299pp-34.1%-291pp256.9%+37.5pp
Returns
Return on equity-115%+14.5pp-129.5%-111pp-18.4%-406pp387.8%+37.9pp
Return on assets-87.4%+11.0pp-98.4%-84.4pp-14%-236pp222.4%+47.3pp
Return on invested capital-138.4%-6.6pp-131.8%-118pp-13.4%
Efficiency
Asset turnover0.7×-0.3×-0.7×1.7×-2.1×3.9×+0.7×
Inventory turnover40×+3.4×36.6×+15.9×20.8×+7.2×13.5×
Liquidity
Current ratio15.4×-0.8×16.2×+3.4×12.7×+4.2×8.6×+2.9×
Quick ratio15.1×-0.9×16×+3.8×12.2×+4.6×7.6×+2.3×
Cash ratio3.8×+0.3×3.5×-0.3×3.9×+1.8×2.1×-0.5×
Leverage
Debt-to-equity0.4×0.0×0.4×0.0×0.4×+0.1×0.3×-0.1×
Debt-to-assets0.3×0.0×0.3×0.0×0.3×+0.1×0.2×0.0×
Per Share
Book value per share$96.46-21.1%$122.33-24.8%$162.64-5.8%$172.64+114%
Valuation
Market capitalization$42.9B-66.5%$128B-30.0%$182.78B-24.3%$241.51B-40.7%
Enterprise value$39.9B-68.0%$124.53B-28.9%$175.08B-24.6%$232.27B-40.0%
Price / sales17.2×-9.7×26.9×+8.8×18.1×+6.8×11.3×-40.5×
Price / book4.6×-6.1×10.7×-0.8×11.5×-1.9×13.4×-37.3×
EV / sales16×-10.1×26.1×+8.8×17.4×+6.5×10.9×-37.6×
Earnings yield-114.1%-53.8pp-60.3%-49.1pp-11.1%-94.5pp83.4%+62.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Moderna's profit margins?
Moderna (MRNA) runs a 22.1% gross margin and a -153.3% operating margin, with a -143.6% net margin.
Where do Moderna's ratios come from?
Every ratio is computed from Moderna's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.